PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Trauma Acute Care Surg. Author manuscript; available in PMC 2014 May 1.
Published in final edited form as:
PMCID: PMC3638007
NIHMSID: NIHMS454088

A principal component analysis of coagulation after trauma

Abstract

Background

Clotting factor abnormalities underlying acute traumatic coagulopathy are poorly understood, with application of traditional regression techniques confounded by collinearity. We hypothesized that principal components analysis (PCA), a pattern-finding and data reduction technique, would identify clinically predictive patterns in the complex clotting factor milieu after trauma.

Methods

Plasma was prospectively collected from 163 critically-injured trauma patients. Prothrombin, Factors V, VII, VIII, IX, X, D-dimer, activated and native Protein C, and antithrombin III levels were assayed, and subjected to non-linear PCA to identify principal components (PCs).

Results

Of 163 patients, 19.0% were coagulopathic on admission. PCA identified 3 significant PCs, accounting for 67.5% of overall variance. PC1 identified global clotting factor depletion; PC2 the activation of Protein C and fibrinolysis; and PC3 Factor VII elevation and VIII depletion. PC1 score correlated with penetrating injury and injury severity, predicting coagulopathy (OR 4.67, p<0.001) and mortality (OR 1.47, p=0.032). PC2 score correlated with injury severity, acidosis, and shock, and significantly predicted ventilator-associated pneumonia (OR 1.59, p=0.008), acute lung injury (OR 2.24, p<0.001), multiorgan failure (OR 1.83, p=0.002), and mortality (OR 1.62, p=0.006), but was not associated with INR- or PTT-based coagulopathy (p>0.200). PC3 did not significantly predict outcomes.

Conclusions

PCA identifies distinct patterns of coagulopathy: depletion coagulopathy predicts mortality and INR/PTT elevation, while fibrinolytic coagulopathy predicts infection, end-organ failure, and mortality, without detectable differences in INR or PTT. While depletion coagulopathy is intuitive, fibrinolytic coagulopathy may be a distinct but often overlapping entity with differential effects on outcomes.

Level of evidence

Prognostic study, Level III

Keywords: Coagulopathy, principal components analysis, fibrinolysis

BACKGROUND

Hemorrhage remains the leading cause of potentially preventable death after trauma, complicated in up to a third of injured patients by coagulation abnormalities present on arrival to the emergency department.1 Although well-studied, the importance of specific clotting factor abnormalities to the complex phenomenon of acute traumatic coagulopathy is poorly understood. Strong correlations between clotting factor levels pose a significant challenge to identifying the isolated importance of any individual factor. This collinearity makes standard regression techniques prone to unstable results, difficult to generalize, and at risk of identifying spurious statistical significance. Several mathematical techniques exist to more clearly describe the patterns that exist in such complex, correlated data sets, and to associate these patterns with binary outcomes; principal component analysis (PCA) is one such method.

PCA is a statistical pattern detection tool that distills a complex set of inter-correlations down to essential clusters of variables that move together as groups. To begin, a dataset of correlated variables is decomposed into a smaller set of uncorrelated synthetic multi-variables. A best-fit plane is described in this multivariate space, the axes of which are termed ‘principal components’ (PCs); the location of each individual data point in multivariate space can then be specifically described relevant to these PCs. In this sense, PCA can be thought of as a multivariate form of the Pearson correlation, in which the best-fit line is replaced by a best-fit multivariate plane. The dataset described here contains arrival clotting factor measurements in a panel of critically injured patients, in which many of the individual factor levels are highly correlated with each other. The application of PCA transforms each patient’s individual clotting factor measurements into a smaller set of PC ‘scores’, which can be interpreted as individual patient locations within multivariate outcome space. Furthermore, each PC can be broken down into ‘factor loadings’ that describe both the contribution of each individual clotting factor into the calculation of that PC score as well as each factor’s relationships with other factors. A detailed explanation of the rationale and methodology of PCA is available in the Supplemental Digital Content.

As an example, a PC controlled entirely by a single predictor would have a loading coefficient of +1.0 for the predictor in question, with all other predictor coefficients equal to zero; in contrast, a PC determined by mixed contributions from multiple factors would have loading coefficients spanning values from −1.0 to +1.0 for each contributing factor, corresponding to positive and inverse Pearson correlations. Intuitively, PCs describe the internal structure of a set of correlated measurements allowing patients to be grouped by global patterns of clotting factor perturbations as defined by high or low PC scores, and the clotting factor interrelationships that define each group can be described. For a set of highly interrelated predictors such as clotting factor measurements, PCA accommodates degrees of collinearity that would make standard regression approaches unstable.

Therefore, we hypothesized that PCA would identify clinically predictive patterns in the complex clotting factor milieu after trauma. In this study, we apply PCA to identify and examine the clotting factor relationships underlying these clinical patterns, and correlate these with outcomes in a panel of critically injured patients.

METHODS

Plasma was collected from 163 critically injured trauma patients on arrival to the emergency department of an urban Level I trauma center from 2/2005 to 10/2010 as part of an on-going clinical study.2 Consecutive patients triggering activation of the highest level of a two-tiered triage system during the study period were prospectively enrolled under a waiver of consent; patients aged <18 years old, those with >5% body surface area burns, those who received >2 liters of intravenous fluid prior to arrival, and those transferred from another institution were excluded. Patients were retrospectively excluded if informed consent was unobtainable or declined. Admission blood samples were collected via initial placement of a 16g or larger peripheral IV into 3.2% (0.109M) sodium citrate, and processed within 3h of being drawn; sample collection methodology is described in detail elsewhere.2 Activity levels of Factors II, V, VII, VIII, IX, and X, antithrombin III and Protein C, as well as antigen D-dimer levels were assayed using a Stago Compact Functional Coagulation Analyzer (Diagnostica Stago; Parsippany, NJ). Activated Protein C was assayed using an established ELISA method reported elsewhere.3 Demographics, laboratory and resuscitation data, and outcomes were collected in parallel. Injury was assessed by injury severity score (ISS).4 Acute lung injury was based on the American-European consensus definition.5 Multiorgan failure (MOF) was defined as a multiple organ dysfunction score of >3 using established Denver criteria.6 The study was approved by the University of California Committee on Human Research.

Non-linear PCA was performed using SPSS categories CAT-PCA (IBM; Chicago, IL); specific details are available in the Supplemental Digital Content Methods. Possible nonlinear correlations among coagulation factors were accounted for in the input stage, resulting in an output of continuous, linear PC scores and PC loadings7; see Supplemental Digital Content Figure 1. All measured factor levels were included as predictors: prothrombin, Factors V, VII, VIII, IX, and X, D-dimer, activated Protein C, Protein C, and antithrombin III. PCs were considered significant for eigenvalues greater than or equal to 1.0 (see Supplemental Digital Content Figure 2); factor loadings were considered significant for coefficients greater than or equal to 0.3. Continuous PC scores were calculated for each patient along each PC axis, and differences between the highest and lowest quartile of patients for each significant PC were examined using standard univariate statistics. The predictive capacities of independent PC scores were evaluated using unadjusted logistic regression for the binary outcomes of mortality, multiorgan failure, acute lung injury, and ventilator-associated pneumonia (VAP), and for standard definitions of coagulopathy determined by admission international normalized ratio (INR) and partial thromboplastin time (PTT).

Data are presented as mean ± standard deviation, median (interquartile range [IQR]), or percentage; univariate comparisons were made using Student’s t-test for normally distributed data, Wilcoxon rank-sum testing for skewed data, and Fisher’s exact test for proportions. Missing predictor data was imputed using multiple imputation; results were similar to those obtained using only complete data as well as using a dataset completed with population means (data not shown). An alpha of 0.05 was considered significant. All analysis was performed by the authors using SPSS Categories (IBM; Chicago, IL) and Stata version 12 (StataCorp; College Station, TX).

RESULTS

Our 163-patient study population had mean age 41.3±19.3y and mean injury severity score 23.2±5.4; there was 31.0% penetrating and 61.2% brain injury. Of 163 patients, 22 (19.0%) were coagulopathic on arrival as defined by INR ≤1.3, and 56 (34.4%) were coagulopathic as defined by PTT ≤30. Non-linear PCA identified 7 independent PCs, together accounting for 92.0% of the variance present in the data. PCs 1, 2, and 3 were considered significant (eigenvalues greater than 1.0); these together accounted for 67.5% of total variance. Eigenvalues, percentage of variance explained, and the factor loading matrix for all individual clotting factors for the three significant PCs are shown in Table 1. Factor loadings were considered significant for loading coefficients greater than or equal to 0.3.

Table 1
Composition of principal components.

PC1 accounted for 43.9% of overall variance, including significant negative factor loading on (analogous to inverse Pearson correlation with) prothrombin, Factors V, VII, VIII, IX, X, Protein C, and antithrombin III (Table 1). To identify patient-level characteristics associated with high PC1 scores, patients with the highest quartile of PC1 score were compared to those in the lowest quartile (Table 2). Patients in the highest quartile of PC1 score had significantly more common penetrating injury (34.2% vs. 12.5%, p=0.035) and more severe injury (mean ISS 32.2 vs. 23.8, p=0.011) compared to those in the lowest quartile. High PC1 patients also had significantly elevated admission INR (median 1.2 vs. 1.0, p<0.001) and PTT (median 32.6 vs. 27.0 sec, p<0.001), as well as lower admission platelet count (mean 245 vs. 311 *103/uL, p<0.001). High PC1 patients also had significantly higher transfusion requirements for red blood cells (median 5 vs. 0 units, p<0.001), plasma (median 2 vs. 0 units, p<0.001), and platelets (median 0 [IQR 0-2] vs. 0 [0] units, p=0.003), and significantly higher mechanical ventilation requirements (median 6.5 vs. 17.5 ventilator-free days, p=0.016). Expressed in terms of odds ratios, each unit increase in PC1 score was associated with a 4.68-fold higher incidence of INR-based coagulopathy (p<0.001), a 3.35-fold higher incidence of PTT-based coagulopathy (p<0.001), and 1.48-fold higher mortality (p=0.032).

Table 2
Patient characteristics by first principal component (PC1).

PC2 accounted for 13.4% of overall variance, including significant positive factor loading on (analogous to positive Pearson correlation with) Factor VIII, D-dimer, and activated Protein C levels (Table 1). Similarly to above, patients in the highest PC2 quartile were again compared to those in the lowest (Table 3). High PC2 patients had more severe injury (mean ISS 37.3 vs. 23.0, p<0.001), acidosis (mean pH 7.27 vs. 7.23, p=0.032), and base deficit (mean −8.4 vs. −5.5, p=0.029). High PC2 patients received less prehospital intravenous fluid (median 0 vs. 500mL), consistent with expedited transport. Despite these differences in injury and shock severity, admission INR and PTT did not differ significantly by PC2 quartile (p=0.440 and p=0.756, respectively), although admission platelet count was higher in the high PC2 population (mean 288 vs. 238 *103/uL, p=0.015). High PC2 patients had significantly higher transfusion requirements for red blood cells (median 6 vs. 0 units, p<0.001), plasma (median 4 vs. 0 units, p<0.001), and platelets (median 0 [IQR 0-2] vs. 0 [0], p=0.002). In terms of outcomes, high PC2 patients had prolonged ICU (median 12 vs. 4.5 days, p=0.003) and total hospital stays (median 22.5 vs. 8.5 days, p=0.004), and significantly higher mechanical ventilation requirements (median 2 vs. 22 ventilator-free days, p=0.002). The incidences of ventilator-associated pneumonia (55.0% vs. 29.8%, p=0.028), acute lung injury (73.5% vs. 26.7%, p<0.001), multiorgan failure (32.5% vs. 4.2%, p<0.001), and mortality (37.5% vs. 16.7%, p=0.031) were all markedly higher in the high PC2 population. Expressed in terms of odds ratios, PC2 score was not associated with significant increases in the incidence of either INR- or PTT-based coagulopathy (p=0.220 and p=0.340, respectively); however, each unit increase in PC2 score was associated with a 1.59-fold higher incidence of ventilator-associated pneumonia, a 2.24-fold higher incidence of acute lung injury, a 1.83-fold higher incidence of multiorgan failure (p=0.002), and 1.62-fold higher mortality (p=0.006).

Table 3
Patient characteristics by second principal component (PC2).

PC3 accounted for 10.1% of overall variance, including significant positive factor loading with Factor VII and activated Protein C, and significant negative loading with Factor VIII (Table 1). Patients in the highest PC3 quartile had significantly better Glasgow Coma Scores (median 9 vs. 6, p=0.034) and lower admission PTT (median 26.6 vs. 28.8 sec, p<0.001); high PC3 patients also had a lower incidence of acute lung injury (40.0% vs. 67.6%, p=0.033; Table 4). Unit increases in PC3 were associated with a 1.44-fold increase in the incidence of PTT-based coagulopathy (p=0.041); however, PC3 scores were not significantly associated with other measured outcomes (all other p>0.05).

Table 4
Patient characteristics by third principal component (PC3).

In order to graphically assess inter-relationships between principal components and their relationship to outcomes, scatter plots were generated representing each patient in multivariate space by PC1 and PC2 score (Figure 1). Visually, the majority of patients with a prolonged INR and PTT are seen to have an elevated PC1 score; these are equally balanced between high and low PC2 scores (Figure 1a and 1b). In comparison, the majority of patients with multiorgan failure and mortality are seen to have an elevated PC2 score; these are equally balanced between high and low PC1 scores (Figure 1c and 1d). Odds ratio data for all binary outcomes assessed are summarized in Table 5.

Figure 1Figure 1Figure 1Figure 1
Plots of patient scores within multivariate principal component space, by binary outcomes. Representative two-dimensional (PC1-PC2 space) plots provided. (a) International normalized ratio (INR) ≤ 1.3, (b) partial thromboplastin time (PTT) ≤ ...
Table 5
Principal component scores as predictors of outcomes.

DISCUSSION

Here we describe the use of PCA to interrogate the data structure of clotting factor levels in a panel of 163 critically-injured trauma patients. Three significant uncorrelated multivariate components were identified, together explaining 67.5% of the total variance in observed clotting factor measurements. PC1 accounted for 43.2% of overall variance, and consisted of significant negative loading coefficients for all procoagulant clotting factors, as well as the anticoagulants Protein C and antithrombin III. Intuitively, PC1 identifies global clotting factor depletion, and its patient-level values are associated with increased incidences of admission coagulopathy as well as mortality. PC2 accounted for 13.4% of variance, consisting principally of significant positive factor loading on D-dimer and activated Protein C levels. Intuitively, PC2 identifies a fibrinolytic component to the clotting factor milieu; interestingly, this component is not significantly associated with admission coagulopathy by INR or PTT-based definitions, but is significantly associated with ventilator-associated pneumonia, acute lung injury, multiorgan failure, and mortality. PC3 accounted for 10.1% of variance, consisting principally of significant negative loading on Factor VIII, with smaller contributions from Factor VII and activated Protein C. Intuitively, PC3 may account for an element of coagulopathy associated with consumption-driven depletion of Factor VIII; PC3 was associated only with admission PTT-based coagulopathy.

Depletion coagulopathy

The global procoagulant depletion phenotype described by PC1 matches the clinical intuition that patients with overwhelming tissue injury and acute hemorrhage frequently present with coagulopathy resulting from clotting factor consumption. The early recognition of this ‘vicious cycle’ of self-perpetuating consumptive coagulopathy is a mainstay of trauma resuscitation,8 with recent studies extending these clinical observations to confirm the association of specific clotting factor deficits to poor outcomes after injury.9 The global procoagulant depletion phenotype reflected by PC1 and its association with both coagulopathy and mortality reflect the clinical intuition that clotting factor depletion must be anticipated and treated early in order to minimize its deleterious effects; precisely this insight has driven recent trends in plasma-based hemostatic resuscitation therapy for critically injured patients.10,11

Fibrinolytic coagulopathy

The fibrinolytic phenotype described by PC2 is significantly associated with multiple functional outcomes, but is interestingly not associated with standard admission laboratory values such as INR or PTT. This subtlety supports the hypothesis that injury-induced activation of endogenous anticoagulants and other systemic effectors, as opposed to consumptive depletion of procoagulant factors alone, plays a critical role in the pathophysiology of acute traumatic coagulopathy. Recent work suggests several candidate biochemical pathways that may mediate dysfunctional coagulation after trauma independently of clotting factor depletion, including catecholamine-mediated degradation of the endothelial glycocalyx12,13 and activation of the Protein C system.2,3 While activated Protein C mediates receptor-independent proteolysis of activated Factors Va and VIIIa as well as derepression of fibrinolysis,2 it may also play an additional receptor-dependent role in potentiating the systemic inflammatory response.3 Kerschen et al. recently showed that a recombinant form of activated Protein C with targeted mutation leading to <10% anticoagulant activity is equivalent to native protein in reducing mortality in sepsis models in mice.14 A prospective study of clotting factor levels in 71 injured patients identified a significant negative correlation between severity of systemic hypoperfusion after injury and the activity of several procoagulant factors, but found that decreased Factor V activity may occur via a consumption-independent mechanism such as Protein C-mediated cleavage.15

This identification of PC2 as a fibrinolytic component is also consistent with a growing recognition of the importance of hyperfibrinolysis to acute traumatic coagulopathy. Hyperfibrinolysis is estimate to occur from 3% to 20% of significantly-injured patients, with mortality spanning 38.5% to 100%.16 At the biochemical level, the presence of hyperfibrinolysis is associated with significantly elevated levels of D-dimer and activated Protein C.17 Recent intriguing data suggest that the use of plasminogen-targeted antifibrinolytics such as tranexamic acid (TXA) may provide the missing pharmacologic treatment for the hyperfibrinolytic component of acute traumatic coagulopathy.18,19 Taken together, these results suggest that aggressive clotting factor repletion by empiric plasma-based therapies may inadequately treat the fibrinolytic component of acute traumatic coagulopathy, and that targeted therapies are a promising area of active investigation.

Study limitations

As with other single-center prospective studies examining the relationship between admission clotting factor studies and outcomes, several limitations are important to interpretation of this data. Although our sample size is modest, highly-cited work in PCA suggests that 5-10 samples for each predictor included is adequate for robust results,20,21 which our 163-patient panel well exceeds for our 10-predictor model. Importantly, this analysis does not provide for strict causal interpretation; neither PCs themselves nor the individual patient PC scores provided by PCA are directly clinically interpretable. Furthermore, the PCA model itself is not generalizable or portable, but is only applicable to the dataset from which it is derived; PC scores cannot be derived for novel patients outside of the dataset presented here. For this exploratory analysis, we included all classical clotting factor measurements available; however, other relevant physiological measures (such as pH or temperature) and clotting cascade elements (such as calcium and fibrinogen) were not uniformly available. Thus the final PCA model may be sensitive to predictor selection. Cognates to common predictor selection strategies for regression analysis (such as forward/backward and information criteria-based selection) are not well-established for the construction of PCA models, and will require detailed sensitivity analyses to validate. Overall, however, the purpose of the current study was not to construct a comprehensive predictive model, but instead to interrogate the clotting cascade for clinically compelling patterns. We suggest that these patterns identify unique groups of patients that would otherwise go undetected based on standard clinical characteristics alone, and that the further analysis of these groups may identify novel molecular markers and potential therapeutic targets.

Summary

Taken together, these results suggest that PCA accurately identifies patterns embedded in the complex milieu of the coagulation cascade in injured patients. The independent consumptive and fibrinolytic components identified here show robust correlation with patient-level outcomes, and match prevailing clinical intuition regarding drivers of acute traumatic coagulopathy. In particular, the fibrinolytic phenotype is associated with markedly poor outcomes but not with abnormalities in INR or PTT, highlighting the inadequacy of these measures in describing the complexity of traumatic coagulopathy and the need for validated markers of abnormal fibrinolysis after trauma. Whereas standard regression techniques are problematic for investigating the role of clotting factors in isolation, PCA is well-suited to address just such highly collinear systems of predictors as patterns. The pattern-finding capability demonstrated here holds promise for elucidating critical mechanisms underlying the pathophysiology of acute traumatic coagulopathy. Further development of data-driven analytical methods such as PCA may ultimately provide critical insights to drive advances in clinical care.

Supplementary Material

01

Supplementary Figure 1. Standard workflow for PCA applied to coagulation factors from 163 patients. Bivariate cross-correlations among all coagulation factors were calculated, and this correlation matrix was subjected to eigenvalue decomposition to yield the lower dimensional variable (‘PC1’) that reflects the intersection of shared variance in the dataset. This method is repeated multiple times to derive orthogonal PCs that each account for an independent cluster of variance in the dataset, in descending rank order for the percentage of variance explained.

Supplementary Figure 2. Application of standard PC extraction and naming rules to coagulation data. A) Kaiser rule suggests retaining 3 PCs with Eigenvalues > 1.0 and discarding the rest. B) Scree plot suggests cutting 2 PCs that lie above the elbow of the plot. C) Total variance explained with the inclusion of each successive PC, indicating that by retaining the first 3 PCs, nearly 70% of the variance in the dataset is accounted for.

Acknowledgments

Funding: Supported by NIH T32 GM-08258-20 (MEK), NIH NS-067092 (ARF), and NIH GM-085689 (MJC)

Footnotes

AUTHOR CONTRIBUTIONS MEK, ARF, and MJC prepared the manuscript, performed all data analysis, and take full responsibility for the data as presented.

Conflicts of interest: None

Meetings: Oral abstract presentation at the 2012 annual meeting of the American Association for the Surgery of Trauma: Kauai, Hawaii, 9/2012

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

1. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008 Oct;65(4):748–754. [PubMed]
2. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007 May;245(5):812–818. [PubMed]
3. Cohen MJ, Call M, Nelson M, et al. Critical Role of Activated Protein C in Early Coagulopathy and Later Organ Failure, Infection and Death in Trauma Patients. Ann Surg. 2011 Dec 1; [PMC free article] [PubMed]
4. Baker SP, O’Neill B, Haddon W, Jr., Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974 Mar;14(3):187–196. [PubMed]
5. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American journal of respiratory and critical care medicine. 1994 Mar;149(3 Pt 1):818–824. [PubMed]
6. Sauaia A, Moore EE, Johnson JL, Ciesla DJ, Biffl WL, Banerjee A. Validation of postinjury multiple organ failure scores. Shock. 2009 May;31(5):438–447. [PubMed]
7. Linting M, Meulman JJ, Groenen PJ, van der Koojj AJ. Nonlinear principal components analysis: introduction and application. Psychological methods. 2007 Sep;12(3):336–358. [PubMed]
8. Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular trauma- -a unified approach. J Trauma. 1982 Aug;22(8):672–679. [PubMed]
9. Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011 Nov;71(5 Suppl 1):S427–434. [PMC free article] [PubMed]
10. Duchesne JC, Holcomb JB. Damage control resuscitation: addressing trauma-induced coagulopathy. Br J Hosp Med (Lond) 2009 Jan;70(1):22–25. [PubMed]
11. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008 Sep;248(3):447–458. [PubMed]
12. Johansson PI, Sorensen AM, Perner A, et al. High sCD40L levels Early After Trauma are Associated with Enhanced Shock, Sympathoadrenal Activation, Tissue and Endothelial Damage, Coagulopathy and Mortality. Journal of thrombosis and haemostasis : JTH. 2011 Dec 12; [PubMed]
13. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011 Aug;254(2):194–200. [PubMed]
14. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. The Journal of experimental medicine. 2007 Oct 1;204(10):2439–2448. [PMC free article] [PubMed]
15. Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma. 2011 Nov;71(5 Suppl 1):S435–440. [PubMed]
16. Schochl H, Voelckel W, Maegele M, Solomon C. Trauma-associated hyperfibrinolysis. Hamostaseologie. 2012 Jan;32(1):22–27. [PubMed]
17. Kutcher ME, Cripps MW, McCreery RC, et al. Criteria for empiric treatment of hyperfibrinolysis after trauma. The journal of trauma and acute care surgery. 2012 Jul;73(1):87–93. [PMC free article] [PubMed]
18. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2011 Oct 17; [PubMed]
19. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul;376(9734):23–32. [PubMed]
20. Nunnally JO. Psychometric Theory. McGraw-Hill; NY: 1978.
21. Tabachnik BG, Fidell LS. Using Multivariate Statistics. 5th ed Pearson Education; Boston: 2007.